MGRX
Mangoceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 1
High Gross Profit Margin
Significant Net Income Decline
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MGRX
Mangoceuticals, Inc.
A company that develops, markets and sells a variety of men's health products and services through a telemedicine platform
15110 N. Dallas Parkway, Suite 600, Dallas, Texas 75248
--
Mangoceuticals, Inc.was founded in Texas on October 7, 2021 to develop, market and sell a variety of men's health products and services through a telemedicine platform. To date, the company has identified men's health telemedicine services and products as an industry that has grown in recent years, especially in areas related to erectile dysfunction. In this regard, Mangoceuticals is currently developing and preparing to market a new brand of erectile dysfunction (ED) product through a proprietary combination of FDA-approved ingredients.
Company Financials
EPS
MGRX has released its 2025 Q2 earnings. EPS was reported at -0.57, versus the expected 0, missing expectations. The chart below visualizes how MGRX has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MGRX has released its 2025 Q3 earnings report, with revenue of 84.25K, reflecting a YoY change of -36.83%, and net profit of -7.62M, showing a YoY change of -281.00%. The Sankey diagram below clearly presents MGRX's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
